What is the maximum duration for unit-dose repackaging BUD?

What is the maximum duration for unit-dose repackaging BUD?

• A. One year from repackaging
• B. 6 months, manufacturer's expiration, or 25% of remaining time — whichever is shortest.
• C. 3 months only
• D. FDA guidelines of 12 months

Answer: (B)

The maximum duration for unit-dose repackaging beyond-use date (BUD) is established to ensure the safety and efficacy of the medication. The correct choice relates to the guidelines that dictate the BUD based on several factors including manufacturer expiration dates, the repackaged form, and the time remaining. When medications are repackaged into unit doses, they should not exceed a BUD of 6 months, unless the manufacturer's expiration date is shorter or there is less than 25% of the remaining time until that expiration. This approach takes into account the stability of the drug, ensuring that patients receive medications that are both effective and safe to use. It protects against potential degradation of the medication and helps to prevent risks associated with administering expired or unstable products. In sum, the rationale behind this particular BUD guideline helps to balance the need for practical use in pharmacies while maintaining the highest standards for patient safety.

The maximum duration for unit-dose repackaging beyond-use date (BUD) is established to ensure the safety and efficacy of the medication. The correct choice relates to the guidelines that dictate the BUD based on several factors including manufacturer expiration dates, the repackaged form, and the time remaining.

When medications are repackaged into unit doses, they should not exceed a BUD of 6 months, unless the manufacturer's expiration date is shorter or there is less than 25% of the remaining time until that expiration. This approach takes into account the stability of the drug, ensuring that patients receive medications that are both effective and safe to use. It protects against potential degradation of the medication and helps to prevent risks associated with administering expired or unstable products.

In sum, the rationale behind this particular BUD guideline helps to balance the need for practical use in pharmacies while maintaining the highest standards for patient safety.